ALAUNOS THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 4, 2021, a trademark application was filed for ALAUNOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALAUNOS THERAPEUTICS trademark a serial number of 97108791. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, March 11, 2024. This trademark is owned by ZIOPHARM Oncology, Inc.. The ALAUNOS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials in the nature of immune cells for the treatment of cancer; cells for medical or clinical use; pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; pharmaceutical preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes

Immune cell therapy services; gene therapy services in the field of oncology
alaunos therapeutics

General Information


Serial Number97108791
Word MarkALAUNOS THERAPEUTICS
Filing DateThursday, November 4, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, March 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials in the nature of immune cells for the treatment of cancer; cells for medical or clinical use; pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; pharmaceutical preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes
Goods and ServicesImmune cell therapy services; gene therapy services in the field of oncology
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALAUNOS THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77005

Party NameALAUNOS THERAPEUTICS, INC.
Party Type12 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHOUSTON, TX 77054

Party NameAlaunos Therapeutics, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Party NameZIOPHARM Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events


Event DateEvent Description
Monday, November 8, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 28, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, May 4, 2022ASSIGNED TO LIE
Wednesday, May 4, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 15, 2022ASSIGNED TO EXAMINER
Wednesday, August 17, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 17, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 19, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 19, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 19, 2023SOU EXTENSION 1 FILED
Friday, May 19, 2023DIVISIONAL REQUEST RECEIVED
Monday, June 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 12, 2023SOU EXTENSION 1 GRANTED
Monday, June 12, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023CORRECTED NOA E-MAILED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023SOU EXTENSION 2 FILED
Tuesday, November 7, 2023SOU EXTENSION 2 GRANTED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2024SOU EXTENSION 3 GRANTED
Monday, March 11, 2024SOU EXTENSION 3 FILED
Friday, May 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED